Earningsreport

Q2/2019 6/30/2019 EPS -0.030 ZacksConsensus N/A ActVsEst N/A - N/A

Actinium Pharmaceuticals, Inc. (Delaware)  (ATNM) 
NASDAQ:AMEX Investor Relations: ir.actiniumpharma.com